Details for New Drug Application (NDA): 021040
✉ Email this page to a colleague
The generic ingredient in PREFEST is estradiol; norgestimate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol; norgestimate profile page.
Summary for 021040
Tradename: | PREFEST |
Applicant: | Teva Womens |
Ingredient: | estradiol; norgestimate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG,1MG;N/A,0.09MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 22, 1999 | TE: | RLD: | Yes |
Expired US Patents for NDA 021040
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Womens | PREFEST | estradiol; norgestimate | TABLET;ORAL | 021040-001 | Oct 22, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Teva Womens | PREFEST | estradiol; norgestimate | TABLET;ORAL | 021040-001 | Oct 22, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Teva Womens | PREFEST | estradiol; norgestimate | TABLET;ORAL | 021040-001 | Oct 22, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Teva Womens | PREFEST | estradiol; norgestimate | TABLET;ORAL | 021040-001 | Oct 22, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription